These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12630582)

  • 1. Antiphospholipid antibodies and the risk of thromboembolic events in valvular heart disease.
    Bulckaen HG; Puisieux FL; Bulckaen ED; Di Pompeo C; Bouillanne OM; Watel AA; Fauchais AL; De Groote P; Millaire A
    Mayo Clin Proc; 2003 Mar; 78(3):294-8. PubMed ID: 12630582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus].
    Reshetniak TM; Kotel'nikova GP; Fomicheva OA; Kliukvina NG; Karpov IuA; Alexandrova EN; Alekberova ZS; Sergakova LM; Nasonova VA; Nasonov EL
    Kardiologiia; 2002; 42(8):38-43. PubMed ID: 12494093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study.
    Perez-Villa F; Font J; Azqueta M; Espinosa G; Pare C; Cervera R; Reverter JC; Ingelmo M; Sanz G
    Arthritis Rheum; 2005 Jun; 53(3):460-7. PubMed ID: 15934103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of stroke patients with antiphospholipid antibodies.
    Terashi H; Uchiyama S; Hashimoto S; Miyazaki K; Tsutsumi Y; Yamazaki M; Iwata M
    Cerebrovasc Dis; 2005; 19(6):384-90. PubMed ID: 15863981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
    Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
    Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Involvement of cardiac valves in antiphospholipid syndrome].
    Sergakova LM; Fomicheva OA; Vil'chinskaia MI; Alekberova ZS; Aleksandrova EN; Karpov IA; Nasonov EL; At'kov OI
    Klin Med (Mosk); 1996; 74(9):39-42. PubMed ID: 9121087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with systemic lupus erythematosus and antiphospholipid syndrome undergoing cardiac valve surgery.
    Arif R; Farag M; Seppelt P; Beller CJ; Ruhparwar A; Karck M; Kallenbach K
    J Heart Valve Dis; 2015 Mar; 24(2):228-35. PubMed ID: 26204691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac abnormalities in antiphospholipid syndrome].
    Meng XM; Zhao Y; Fang LG; Yan XW
    Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):284-6. PubMed ID: 17637264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of antiphospholipid antibodies with valvular heart disease in patients with systemic lupus erythematosus].
    Hosaka K; Okada J; Ogiwara A; Kobayashi A; Kondo H
    Ryumachi; 1994 Feb; 34(1):22-9. PubMed ID: 8146724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Ames PR; Pyke S; Iannaccone L; Brancaccio V
    Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between antiphospholipid antibodies and progression of lower extremity arterial occlusive disease after lower extremity bypass operations.
    Lam EY; Taylor LM; Landry GJ; Porter JM; Moneta GL
    J Vasc Surg; 2001 May; 33(5):976-82. PubMed ID: 11331837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular surgical outcomes in patients with the antiphospholipid syndrome--a case-series.
    Hegde VA; Vivas Y; Shah H; Haybron D; Srinivasan V; Dua A; Gradman A
    Heart Lung Circ; 2007 Dec; 16(6):423-7. PubMed ID: 17611152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antiphospholipid antibodies on cardiac valve lesions in systemic lupus erythematosus: a systematic review and meta-analysis.
    Chen S; Zhou Y; Wang C; Jiang H; Zhao Y; Zhao J; Huang C; Li M; Zhao Y
    Clin Exp Med; 2024 Jul; 24(1):147. PubMed ID: 38960899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
    Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
    Somers E; Magder LS; Petri M
    J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.